This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: University of Massachusetts, Yale University. Active years: 2006-2015.
Company Filing History:
Years Active: 2006-2015
Title: Janet Plescia: Innovator in Protein-Protein Interaction Inhibition
Introduction
Janet Plescia is a notable inventor based in Meriden, CT (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit protein-protein interactions. With a total of 6 patents to her name, her work has the potential to impact therapeutic strategies in cancer treatment.
Latest Patents
Among her latest patents, Janet has disclosed compounds that inhibit Hsp90 protein-protein interactions with IAP proteins. These compounds target interactions with proteins such as Survivin, XIAP, cIAP1, and cIAP2. The methods for identifying and utilizing these compounds are also detailed in her patents, showcasing her innovative approach to addressing complex biological challenges.
Career Highlights
Janet has had a distinguished career, working at prestigious institutions such as the University of Massachusetts and Yale University. Her research has focused on the mechanisms of protein interactions and their implications in disease processes. This work has positioned her as a leading figure in her field.
Collaborations
Throughout her career, Janet has collaborated with esteemed colleagues, including Dario C. Altieri and Whitney Salz. These partnerships have enriched her research and contributed to the advancement of knowledge in protein interactions.
Conclusion
Janet Plescia's innovative work in the field of protein-protein interactions exemplifies her dedication to scientific advancement. Her patents and collaborations reflect her commitment to developing solutions that could lead to significant breakthroughs in medical research.